Effective December 13, 2026, New York State will require most private employers to stock their workplaces with opioid antagonists (antidotes), such as naloxone or Narcan.

On September 23, 2026, the New York State Department of Labor (NYSDOL) published its proposed rules (the “Proposed Rules”), which clarify employer compliance obligations.

Background: Understanding the Law 

Governor Kathy Hochul signed the workplace opioid antagonist requirement into law on December 12, 2025, adding § 27-f (the “Law”) to the New York Labor Law. On February 13, 2026, Governor Hochul signed amendments into law, clarifying the employer scope and exemptions, and delaying the effective date until December 13, 2026.

The Law applies broadly, covering all private employers that are federally required to keep first aid supplies on hand. The Law directs the NYSDOL, in consultation with the New York State Department of Health, to promulgate regulations in advance of the December 13, 2026, effective date.

Coverage under Labor Law § 27-f is tied to federal Occupational Safety and Health Act (OSHA) standards for medical and first aid in the workplace. Generally, worksites that are not in “near proximity” to an infirmary, clinic, or hospital used to treat all injured employees must maintain first aid supplies and will be required to comply with the opioid antagonist mandate. “Near proximity” is not defined in applicable regulations; however, a 2007 OSHA interpretation letter states that “OSHA has long interpreted the term ‘near proximity’ to mean that emergency care must be available within no more than 3-4 minutes from the workplace.”

The Proposed Rules

The Proposed Rules, as drafted, clarify employer obligations, answering questions on how many opioid antagonists employers need, where to store them, and how to obtain them. Although subject to modification after the notice and comment period closes on November 22, 2026, these draft regulations foretell the requirements covered employers face once the law takes effect.

Quantity and Placement

  • Employers must maintain a “sufficient number” of opioid antagonists based on worksite size and layout, staffing levels, whether high-risk populations access the site, the nature of the work, and any history of on-site overdoses. No fixed quantity is required.
  • Supplies must be stored in easily accessible locations; employees should not have to travel through multiple doorways or stairways. Ideally, supplies should be kept near AEDs and other first aid kits in a central, visible location. Locked rooms are discouraged, unless required due to security concerns, as long as quick access is ensured. Supply locations should be communicated to all employees.
  • Medication must remain sealed in the manufacturer’s original packaging with the manufacturer’s instructions, or, in the absence of the original instructions, with instructions provided by the New York State Department of Health, the New York City Department of Health and Mental Hygiene, or New York State’s Drug User Health Training Center of Expertise.

Training

  • Training must address recognizing overdose symptoms, administering opioid antagonists, steps to take before and after administration, contacting emergency responders, and Good Samaritan protections.
  • At least one trained employee must be present during business hours. Employers are encouraged to train additional volunteers, or all employees.

Maintenance and Inspection

  • Employers must regularly inspect supplies to ensure they have not expired, been tampered with, or gone missing.
  • Employers must replace and dispose of expired, used, missing, or compromised doses promptly when discovered. The Rules do not prescribe inspection frequency or disposal methods.
  • The opioid antagonists must be approved by the Food and Drug Administration (FDA), which also publishes expiration dates and storage regulations.

Shared Workplaces

  • Employers sharing a worksite may comply jointly through a written plan. Such a plan must be provided to the NYSDOL upon request.

Cost

  • Compliance costs are expected to be modest. Naloxone is often available at little to no cost through public programs, and free training is already available.
  • Employers can access resources through the Office of Addiction Services and Supports (OASAS). Employers may also be able to obtain free supplies through New York State and New York City

Alignment with Federal Policy

On September 24, 2026, one day following the NYSDOL’s publication of the Proposed Rules, OSHA released guidance for employers on opioid overdose emergencies. OSHA recommends all employers – not just New York employers subject to the Law – maintain opioid antagonists, monitor inventory, and train employees to recognize and respond to overdoses.

What Should Employers Do Now?

With the December 13, 2026 effective date fast approaching, covered New York State employers should:

  • Determine coverage: Assess whether your worksites are subject to the Law.
  • Evaluate quantity and placement: Evaluate how many opioid antagonists you need and where they will be stored.
  • Plan employee training and schedules: Recruit employee volunteers for training. Review employee work schedules to ensure at least one trained employee is present during all operating hours.
  • Procure supplies and establish procedures: Obtain naloxone and implement inspection, replacement, and disposal procedures.
  • Communicate to employees: Inform all staff where opioid antagonists are stored.
  • Monitor for final rules: the public comment closes on November 22, 2026, at which point the NYSDOL may publish final rules that differ from these Proposed Rules.

Looking Forward

New York will likely be the first state with an effective law of this kind, but it was not the first state to enact workplace opioid antagonist legislation. On September 27, 2024, California Governor Gavin Newsom signed AB 1976, directing Cal/OSHA to draft a rulemaking proposal requiring opioid antagonists in the workplace by December 1, 2027. The Standards Board is required to adopt revised standards by December 1, 2028.

Maureen Maher-Patenaude, a Law Clerk—admission pending (not admitted to practice) in Epstein Becker Green’s New York office and Staff Attorney Elizabeth Ledkovsky contributed to this post.

* * * *

If you have questions, please reach out to the author(s).

The Workforce Bulletin blog is currently edited by Adam S. Forman, Greta Ravitsky, Elizabeth S. Torkelsen, and Jennifer Stefanick Barna.

Back to Workforce Bulletin Blog

Search This Blog

Authors

Related Services

Topics

Archives

Jump to Page

Subscribe

Sign up to receive an email notification when new Workforce Bulletin posts are published:

Privacy Preference Center

When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer.

Strictly Necessary Cookies

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

Performance Cookies

These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.